MDVN Related StreetInsider.com Reports
-
Medivation, Inc. (MDVN) Tops Q1 EPS by 5c; Names Directors
-
Trading Radar for 05/09: priceline.com (PCLN), NVIDIA (NVDA), DISH Network (DISH), Dean Foods (DF) Report
-
Goldman Sachs Starts Medivation (MDVN) at Buy, Sees 28% Upside
-
Astellas, Medivation (MDVN) Receive Positive CHMP Opinion on XTANDI
-
Medivation (MDVN), Astellas Plan Inteim Update for XTANDI Phase III
-
Notable Analyst Rating Changes 03/28: (RYAAY) (SM) (EXP) Upgraded; (EXA) (AEIS) (SNX) Downgraded
-
JMP Securities Starts Medivation (MDVN) at Market Outperform
-
Needham & Company Starts Medivation (MDVN) at Buy
-
Medivation, Inc. (MDVN) Tops Q4 EPS by 4c
-
Medivation (MDVN) Reverses after Cowen Research Called into Question by Janney
-
Trading Radar for 02/28: Kohls (KSS), salesforce.com (CRM), Gap (GPS), Cablevision (CVC), Palo Alto Networks (PANW) Report
-
Medivation (MDVN) Says Astellas Becomes Positive on XTANDI U.S. Sales
-
Janney Montgomery Scott Starts Medivation (MDVN) at Buy
-
UBS Starts Medivation (MDVN) at Neutral
-
Notable Analyst Rating Changes 12/04: (FRAN) (GFI) (SFD) Upgraded; (IACI) (CLF) (RGC) Downgraded
-
Barclays Starts Medivation (MDVN) at Equalweight
-
Streetinsider.com's Hot Lunchtime Reads 12/03: (MDVN) (DELL) (QIHU) (AAPL) (F)/(GM)
-
Medivation's (MDVN) Xtandi Could See Strong Upside Following PREVAIL - Analyst
-
Xtandi Off to a Fast Start (MDVN) - Leerink Swann
-
UPDATE: Medivation, Inc. (MDVN) Posts Q3 Loss of 6c/Share
-
Notable ETF Movers of the Day 11/09: (XBI) (SMH) Higher; (XHB) Lower
-
Trading Radar for 11/09: Moneygram (MGI), Ameren (AMRN), Apollo Global (APO), Heartware (HTWR), Overseas Shipholding (OSG) Report
-
Stocks Crossing 50-Day SMA 10/19: (RHI) (MDVN) (PBCT) Above; (BHI) (ETFC) (CPNO) Below
-
Medivation (MDVN), Astellas Issue Update on Enzalutamide Phase 3
-
Maxim Group Starts Medivation (MDVN) at Buy
-
Medivation (MDVN) Effects Two-for-One Forward Split
-
Wedbush Prostate Cancer Survey Reveals JNJ’s (JNJ) Zytiga has Still-Solid Market Position but Medivation’s (MDVN) Xtandi in Good Position at Launch
-
Wedbush Reiterates an 'Outperform' on Medivation (MDVN); Raising PT on Early Approval
-
Streetinsider.com's Hot Lunchtime Reads 09/04: (RENN) (AAPL) (LULU) (NOK) (BKW)
-
Leerink Swann Maintains an 'Outperform' on Medivation (MDVN); Number of Advantages Based on Labeling
-
Brean Murray Carret & Co. Maintains a 'Buy' on Medivation (MDVN); Adjusting Numbers on Xtandi Approval
-
Jefferies Reiterates a 'Buy' on Medivation (MDVN); Xtandi Approved Early
-
Medivation (MDVN) Up ~8% Following Halt for Xtandi Approval
-
Medivation (MDVN) to resume trading at 3:35pm ET
-
FDA Approves Medivation (MDVN), Astellas' Xtandi for Late Stage Prostate Cancer
-
Dendreon (DNDN) Hit After Medivation Wins FDA Approval for Prostate Cancer Drug
-
FDA approves Medivation (MDVN) XTANDI for Prostate Cancer
-
Medivation (MDVN) halted, news pending
-
Medivation (MDVN) Announces Two-for-One Forward Split
-
Viking Global Investors Shows New 5.31% Stake in Medivation, Inc. (MDVN)
-
Medivation (MDVN), Astellas Report Publication of Statistically Significant Data from AFFIRM Phase 3
-
Medivation, Inc. (MDVN) Misses Q2 EPS by 35c
-
Medivation (MDVN) Drops Lower Ahead of Q2 Results, Now Negative on Session
-
Trading Radar for 08/09: NVIDIA (NVDA), James River Coal (JRCC), Fusion-io (FIO), Lionsgate (LGF), Red Robin (RRGB) Report
-
Medivation (MDVN), Astellas Get PDUFA Date from FDA for Enzalutamide
-
Maxim Upgrades Dendreon (DNDN) as the Street is 'Too Bearish' Ahead of Q2 Results
-
Medivation (MDVN) Hits Century Mark
-
FDA Accepts NDA for Medivation's (MDVN) Enzalutamide; $10M Milestone Payment Triggered
-
Medivation (MDVN) Ripe for the Picking on Expected Enzalutamide Approval
-
ThinkEquity Starts Medivation (MDVN) at Buy
Back to MDVN Stock Lookup
